Rare site of Venous thrombosis in IBD

A 31 years old female with known case IBD - CD with stricturing disease involving small bowel was admitted with abdominal pain with abdominal distention since 5 days. She was receiving 100mg azathioprime daily since 1 year. X ray abdomen was not showing air under diaphragm while USG showed moderate ascites with thombosed hepatic veins. 
Triple phase CT showed thrombosed hepatic veins with narrowing of intrahepatic IVC - suggestive of BCS. Her ascites decreased with salt restriction and diuretics, she was also treated with LMWH followed by oral anti coagulation.



IBD patients have an increased risk (2 to 3 times) of venous thromboembolism (VTE) which is a significant cause of morbidity and mortality.

55 % of Gastroenterologists are unaware of VTE guidelines in IBD and 65% gastroenterologists may not use VTE prophylaxis in hospitalized patients with acute severe colitis.

Major sites for VTE – deep vein thrombosis, pulmonary thromboembolism, portal and mesenteric veins

Etiology: Multifactorial – hereditary and acquired
                Dehydration, indwelling catheters, prolonged immobilization, hyperhomocysteinaemia, surgical interventions and active disease  

Non pharmacological prophylaxis:
                Maintain hydration
                Correct vitamin deficiencies – Vitamin B12, B6 and Folic acid (to reduce homocysteine levels)
                Graduated compression stockings or pneumatic devices
                 Early mobilization
Pharmacological prophylaxis:
                 Recommended (ECCO, BSG, ACG) in hospitalized patients with active disease either LMWH or unfractionated heparin (UH). 
                NO RCTS, BASED ON OBSERVATIONAL STUDIES

Treatment:
               Treatment of VTE in IBD is same as those without IBD
             
 If no hemodynamically significant bleeding or indications of thrombolysis >> LMWH is ideal which should be switched to an oral anticoagulant (Duration – not well established)

33 % risk of second episode of VTE within 5 years

The benefits of long term anti-coagulation in reducing recurrent VTE outweigh risk of bleeding, particularly in those who developed VTE in absence of active disease or other transient provoking factors.

IVC filter is indicated in cases of floating thrombi in deep veins and recurrent PE despite anticoagulation and in cases with high risk of bleeding.



VTE is life- threatening extra intestinal manifestation of IBD: Suspects, prevent and treat